Compare · LFST vs REUN
LFST vs REUN
Side-by-side comparison of LifeStance Health Group Inc. (LFST) and Reunion Neuroscience Inc. (REUN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LFST and REUN operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- LFST carries a market cap of $4.82B.
- LFST has hit the wire 8 times in the past 4 weeks while REUN has been quiet.
- LFST has more recent analyst coverage (17 ratings vs 0 for REUN).
- Company
- LifeStance Health Group Inc.
- Reunion Neuroscience Inc.
- Price
- $12.60-1.52%
- $1.13+1.80%
- Market cap
- $4.82B
- -
- 1M return
- +5.97%
- -
- 1Y return
- +143.24%
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 8
- 0
- Recent ratings
- 17
- 0
LifeStance Health Group Inc.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.
Latest LFST
- LifeStance Health Group Announces Pricing of Secondary Public Offering
- SEC Form 424B7 filed by LifeStance Health Group Inc.
- LifeStance Health Group Announces Launch of Secondary Public Offering
- Chief Technology Officer Paunovich Vukasin sold $541,402 worth of shares (42,067 units at $12.87), decreasing direct ownership by 17% to 205,379 units (SEC Form 4)
- Chief Executive Officer Bourdon David disposed of 150,000 shares, decreasing direct ownership by 11% to 1,248,247 units (SEC Form 4)
- LifeStance to Present at Upcoming Investor Conferences
- Chief People Officer Varanakis Ann covered exercise/tax liability with 8,156 shares, decreasing direct ownership by 2% to 413,881 units (SEC Form 4) (for withholding tax)
- Director Deluca Teresa sold $95,100 worth of shares (7,500 units at $12.68), decreasing direct ownership by 7% to 97,093 units (SEC Form 4) (withholding tax)
- Director Deluca Teresa sold $249,993 worth of shares (20,441 units at $12.23), decreasing direct ownership by 16% to 104,593 units (SEC Form 4)
- SEC Form 144 filed by LifeStance Health Group Inc.
Latest REUN
- SEC Form 15-12G filed by Reunion Neuroscience Inc.
- Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
- Reunion Neuroscience Completes Take-Private Setup: Delisting & Consideration Details
- SEC Form 6-K filed by Reunion Neuroscience Inc.
- SEC Form SC 13D/A filed by Reunion Neuroscience Inc. (Amendment)
- SEC Form F-10POS filed by Reunion Neuroscience Inc.
- SEC Form S-8 POS filed by Reunion Neuroscience Inc.
- SEC Form S-8 POS filed by Reunion Neuroscience Inc.
- SEC Form 25-NSE filed by Reunion Neuroscience Inc.
- Reunion Neuroscience Inc. and MPM BioImpact Announce Completion of Plan of Arrangement